開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
Japan Economy Watchers Survey current conditions index for October 46.1, previous 47.0.
2026-11-10
Japan Economy Watchers Survey current conditions index for October 46.1, previous 47.0.
返回
其他消息
2026-11-10
SoftBank Group CFO Yoshimitsu Goto said claims that the group has defaulted on payments for turbine orders are entirely false and that the account in Elon Musk’s post on X is not factual.
SoftBank Group CFO Yoshimitsu Goto said claims that the group has defaulted on payments for turbine orders are entirely false and that the account in Elon Musk’s post on X is not factual.
2026-11-10
China's National Health Commission, National Healthcare Security Administration, National Administration of Traditional Chinese Medicine and the CDC on the 10th issued a notice to further improve safe, rational allocation and use of innovative drugs, focusing on promoting rational allocation, strengthening training and guidance, easing use conditions and improving management. The notice directs implementation of pharmacy-related medical service pricing items, pledges enhanced support measures to
China's National Health Commission, National Healthcare Security Administration, National Administration of Traditional Chinese Medicine and the CDC on the 10th issued a notice to further improve safe, rational allocation and use of innovative drugs, focusing on promoting rational allocation, strengthening training and guidance, easing use conditions and improving management. The notice directs implementation of pharmacy-related medical service pricing items, pledges enhanced support measures to optimize the policy environment for innovative drugs, states medical institutions will not be restricted on total drug varieties/specifications, and clarifies relevant innovative drugs will be excluded from public hospitals' performance-monitoring indicators, including outpatient and inpatient per‑visit drug-cost growth.
Chat with us
, powered by
LiveChat